Rock Springs Capital Management LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2019$6,323,000
-6.9%
587,400
+9.9%
0.25%
+2.4%
Q2 2019$6,792,000
-61.8%
534,400
+16.7%
0.25%
-64.1%
Q1 2019$17,766,000
+91.3%
458,000
+0.3%
0.68%
+56.4%
Q4 2018$9,289,000
-58.4%
456,462
-6.4%
0.44%
-45.9%
Q3 2018$22,356,000
-20.6%
487,600
+2.5%
0.81%
-25.3%
Q2 2018$28,144,000
+0.2%
475,800
+15.2%
1.08%
-9.7%
Q1 2018$28,098,000
-23.9%
412,900
+10.5%
1.20%
-28.4%
Q4 2017$36,920,000
-6.6%
373,500
+13.2%
1.68%
-8.1%
Q3 2017$39,518,000
+143.1%
330,000
+77.4%
1.82%
+122.0%
Q2 2017$16,256,000
+362.5%
186,000
+96.8%
0.82%
+304.4%
Q1 2017$3,515,000
+21.2%
94,5000.0%0.20%
+4.6%
Q4 2016$2,901,000
-37.7%
94,500
+36.0%
0.19%
-33.6%
Q3 2016$4,660,000
+374.1%
69,500
+110.6%
0.29%
+300.0%
Q2 2016$983,000
+6.3%
33,000
+4.8%
0.07%
-6.4%
Q1 2016$925,000
+7.3%
31,500
+186.4%
0.08%
+20.0%
Q4 2015$862,000
-28.0%
11,000
-30.8%
0.06%
-33.0%
Q3 2015$1,198,000
-6.7%
15,900
+44.5%
0.10%
+3.2%
Q2 2015$1,284,000
-77.6%
11,000
-54.6%
0.09%
-82.5%
Q1 2015$5,726,000
+30.1%
24,250
+4.3%
0.54%
+4.1%
Q4 2014$4,401,000
-10.0%
23,250
+13.4%
0.52%
-32.0%
Q3 2014$4,891,000
+1160.6%
20,500
+449.9%
0.76%
+750.6%
Q1 2014$388,000
-88.1%
3,728
-88.2%
0.09%
-92.4%
Q4 2013$3,261,00031,5001.16%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders